FDA Approved Products

Application #TypeSponsorNotesProduct #Drug NameFormStrengthActive IngredientApproval DateMarketing StatusReference Standard
218663ANDACONCORD BIOTECH LTD001TERIFLUNOMIDETABLET;ORAL7MGTERIFLUNOMIDE2025-04-07PrescriptionNo
002TERIFLUNOMIDETABLET;ORAL14MGTERIFLUNOMIDE2025-04-07PrescriptionNo
213112ANDACONCORD BIOTECH LTD001TACROLIMUSCAPSULE;ORALEQ 0.5MG BASETACROLIMUS2020-11-10PrescriptionNo
002TACROLIMUSCAPSULE;ORALEQ 1MG BASETACROLIMUS2020-11-10PrescriptionNo
003TACROLIMUSCAPSULE;ORALEQ 5MG BASETACROLIMUS2020-11-10PrescriptionNo
212087ANDACONCORD BIOTECH LTD001MYCOPHENOLATE MOFETILTABLET;ORAL500MGMYCOPHENOLATE MOFETIL2020-07-31PrescriptionNo
211173ANDACONCORD BIOTECH LTD001MYCOPHENOLATE SODIUMTABLET, DELAYED RELEASE;ORALEQ 180MG BASEMYCOPHENOLATE SODIUM2019-12-13PrescriptionNo
002MYCOPHENOLATE SODIUMTABLET, DELAYED RELEASE;ORALEQ 360MG BASEMYCOPHENOLATE SODIUM2019-12-13PrescriptionNo
210181ANDACONCORD BIOTECH LTD001MYCOPHENOLATE MOFETILCAPSULE;ORAL250MGMYCOPHENOLATE MOFETIL2019-01-08PrescriptionNo